PulseAugur
EN
LIVE 14:45:27
ENTITY Obutinib

Obutinib

PulseAugur coverage of Obutinib — every cluster mentioning Obutinib across labs, papers, and developer communities, ranked by signal.

Show in brief
Total · 30d
0
1 over 90d
Releases · 30d
0
0 over 90d
Papers · 30d
0
0 over 90d
TIER MIX · 90D
TOPICS
TIMELINE
  1. 2026-05-28 product_launch Innocare Pharma's BTK inhibitor Obutinib received acceptance for its new drug application to treat primary immune thrombocytopenia (ITP). source
RECENT · PAGE 1/1 · 1 TOTAL
  1. RESEARCH · CL_56722 ·

    Li Auto delivers 95K vehicles in Q1, Innocare's ITP drug accepted

    Li Auto reported first-quarter deliveries of 95,142 vehicles, a 2.5% increase year-over-year, reclaiming the top sales spot among Chinese brands in the new energy vehicle market above 200,000 yuan. The company's first-q…